The Quantum Group Co-Sponsors Biotechnology Lecture in Wellington, Florida

Name	Symbol	Market	Type
Defiance Quantum ETF	AMEX:QTUM	AMEX	Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.00	0.00%	57.72				0	01:00:00

Defiance Quantum ETF (AMEX:QTUM)
Historical Stock Chart

From Oct 2019 to Oct 2024

Click Here for more Defiance Quantum ETF Charts.

The Quantum Group Co-Sponsors Biotechnology Lecture in Wellington, Florida WELLINGTON, Fla., Aug. 12 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (OTC:QTUM) (BULLETIN BOARD: QTUM) announces its co-sponsorship of the third installment of the Florida International University Provost Lecture Series 2004 entitled "Biotechnology and Its Impact on Health Care and the Economy of South Florida" with Florida International University and the Village of Wellington. President of The Quantum Group Noel J. Guillama commented, "With over 75 million baby boomers set to begin to retire in just eight years, and over $3 trillion projected to be spent on their healthcare needs, we must look towards advances in biotechnology to both improve the lifestyles of the future and to provide a more effective and responsive healthcare system." Guillama, a recognized expert in the field of healthcare and healthcare services who also serves as a director of the FIU Foundation and a member of the Village of Wellington Education Committee, added, "The mission of the Quantum Group is to provide solutions -- and education of the public is an integral factor in responding to the healthcare crisis of our nation." This lecture is scheduled for Tuesday, August 17, beginning at 6:30 pm and will feature a presentation by Dr. Richard Schoephoerster, distinguished professor and chair of FIU's department of biomedical engineering. Schoephoerster, who maintains an active research program in the area of biofluid mechanics and cardiovascular devices with an emphasis on cardiac applications, also serves on the Governor's Biomedical Research Advisory Council. He plans to share his knowledge and expertise in this area -. which examines the use of biological processes to provide useful solutions to some of life's most vexing medical problems -. by presenting on biotechnology's impact on the delivery of healthcare and its role in the sustainability and growth of local South Florida economies. "The field is in the midst of tremendous growth throughout the nation, and FIU's mission within this field is to integrate the local academia, clinical medicine and biomedical industry to position South Florida as one of the nation's hotbeds of activity," said Schoephoerster, with respect to his planned presentation. "FIU is home to the only public biomedical engineering program in South Florida, and this puts the responsibility of leadership on us. We are ready for the challenge," he added. A panel of community leaders within the biotechnology field and county government will be on hand for a follow-up discussion immediately following the presentation. Scheduled to participate as panelists are Robert Weisman, county administrator for Palm Beach County, and Dr. Pat Griffin, Professor of Drug Discovery and head of Drug Metabolism and Pharmacokinetics at Scripps Florida, among others. This program will take place at the Wellington Community Center Meeting Hall, located at 12165 West Forest Hill Blvd. in Palm Beach County. The community event is open to the public, and admission and self-parking are free. Remaining lectures in the series are scheduled for the third Tuesday of the month, as well, on September 21, October 19, and November 16. To reserve a seat and/or for more information on this program, please contact FIU's Continuing and Professional Studies office at 305-348-5669, or 800-850-8523 toll-free. The Quantum Group, Inc., is a Wellington, Florida-based healthcare company in its development stage, providing outsourcing, technology-based solutions, government compliance, education, policy consulting and venture management to the healthcare industry. Quantum is currently involved in: outsourcing for physicians, managed care organizations, healthcare facilities, and physician associations; developing three patent-pending healthcare solutions identified as Cybernaptics(SM), Quantum Quotient(SM) (or QX2(SM)) and MDAutomated(SM), all with the intention to provide new efficiencies to the $1.6 billion U.S. healthcare system; and providing leading-edge healthcare services to consumers. The Quantum Group -- "healthcare solutions for a new generation."(SM) Media Contact: Danielle Amodio Director, Corporate Communications The Quantum Group, Inc. http://www.thequantumgroupinc.com/ 561-798.9800 DATASOURCE: The Quantum Group CONTACT: Danielle Amodio, Director, Corporate Communications, The Quantum Group, Inc., +1-561-798-9800 Web site: http://www.thequantumgroupinc.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

QTUM Defiance Quantum ETF